CFO
BSX icon

CVA Family Office’s Boston Scientific BSX Stock Holding History

CVA Family Office’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$71.7K Sell
1,679
-769
-31% -$41.8K 0.01% 543
2026
Q1 		$154K Sell
2,448
-32
-1% -$2.56K 0.02% 367
2025
Q4 		$236K Sell
2,480
-215
-8% -$21.1K 0.03% 270
2025
Q3 		$263K Buy
2,695
+49
+2% +$5.07K 0.03% 247
2025
Q2 		$284K Sell
2,646
-22
-0.8% -$2.23K 0.04% 235
2025
Q1 		$269K Buy
2,668
+247
+10% +$24.9K 0.04% 232
2024
Q4 		$216K Buy
2,421
+481
+25% +$42.3K 0.03% 262
2024
Q3 		$163K Buy
1,940
+31
+2% +$2.44K 0.03% 295
2024
Q2 		$147K Buy
1,909
+131
+7% +$9.59K 0.03% 290
2024
Q1 		$122K Buy
1,778
+8
+0.5% +$514 0.02% 324
2023
Q4 		$102K Buy
+1,770
New +$94.5K 0.02% 331
2023
Q3 		– Sell
-1,992
Closed -$108K – 329
2023
Q2 		$108K Buy
1,992
+252
+14% +$13.2K 0.02% 302
2023
Q1 		$87.1K Sell
1,740
-30
-2% -$1.41K 0.02% 333
2022
Q4 		$81.9K Buy
1,770
+770
+77% +$33.3K 0.02% 309
2022
Q3 		$39K Buy
1,000
+905
+953% +$36.3K 0.01% 421
2022
Q2 		$4K Sell
95
-2,020
-96% -$82.2K ﹤0.01% 757
2022
Q1 		$94K Buy
2,115
+1,455
+220% +$63.1K 0.02% 268
2021
Q4 		$28K Buy
+660
New +$27.7K 0.01% 467
2021
Q3 		– Sell
-1,885
Closed -$81K – 431
2021
Q2 		$81K Buy
1,885
+1,340
+246% +$56.4K 0.02% 272
2021
Q1 		$21K Buy
+545
New +$20.6K 0.01% 401

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
California State Teachers Retirement System (CalSTRS)
California State Teachers Retirement System (CalSTRS) West Sacramento, California $782B AUM 28.39% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

CVA Family Office's BSX Position: Q2 2026 in Review

CVA Family Office reduced its Boston Scientific (BSX) stake by 31% in Q2 2026, selling an estimated $41.8K and leaving 1,679 shares worth $71.7K. The position accounts for 0.01% of the portfolio, ranked #543.

CVA Family Office first reported a position in BSX in Q1 2021 and has held it in 20 quarters since. The position peaked at $284K in Q2 2025. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • CVA Family Office held 1,679 shares of Boston Scientific worth $71.7K as of Q2 2026.
  • CVA Family Office sold 769 Boston Scientific shares in Q2 2026, an estimated $41.8K.
  • Boston Scientific made up 0.01% of CVA Family Office's portfolio in Q2 2026, its #543 holding.
  • CVA Family Office first reported a position in Boston Scientific in Q1 2021 and has held it in 20 quarters since.
  • CVA Family Office's Boston Scientific position peaked at $284K in Q2 2025.
  • 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on CVA Family Office's 13F filing for Q2 2026, filed 7 Aug 2026.